Edition:
United Kingdom

Esperion Therapeutics Inc (ESPR.OQ)

ESPR.OQ on NASDAQ Stock Exchange Global Market

51.49USD
7 Dec 2018
Change (% chg)

$-2.62 (-4.84%)
Prev Close
$54.11
Open
$54.10
Day's High
$55.43
Day's Low
$51.17
Volume
161,405
Avg. Vol
245,440
52-wk High
$82.68
52-wk Low
$33.06

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -1.862
Jun '18 0.00 -1.707
Mar '18 0.00 -1.734
FY 2017 Dec '17 0.00 -1.444
Sep '17 0.00 -1.860
Jun '17 0.00 -1.918
Mar '17 0.00 -1.797
FY 2016 Dec '16 0.00 -1.284
Sep '16 0.00 -0.772
Jun '16 0.00 -0.623
Mar '16 0.00 -0.647
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 7 0.00 0.00 0.00 0.00
Quarter Ending Mar-19 1 0.00 0.00 0.00 --
Year Ending Dec-18 10 10.00 100.00 0.00 32.00
Year Ending Dec-19 12 20.83 150.00 0.00 14.29
Earnings (per share)
Quarter Ending Dec-18 12 -1.44 -1.05 -1.84 -1.46
Quarter Ending Mar-19 3 -1.34 -1.32 -1.39 --
Year Ending Dec-18 12 -6.69 -6.35 -7.13 -5.63
Year Ending Dec-19 13 -5.58 -1.62 -8.62 -5.76
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 92.25 33.63
P/E High - Last 5 Yrs. -- 323.36 45.43
P/E Low - Last 5 Yrs. -- 90.29 24.43
Beta 2.67 0.91 0.90
Price to Sales (TTM) -- 116.41 5.77
Price to Book (MRQ) 8.24 15.60 5.12
Price to Tangible Book (MRQ) 9.37 14.89 6.54
Price to Cash Flow (TTM) -- 72.75 23.57
% Owned Institutions -- 12.59 1.83

Dividends

  Company industry sector
Dividend Yield -- 0.39 1.49
Dividend Yield - 5 Year Avg -- 0.31 1.50
Dividend 5 Year Growth Rate -- 2.65 5.08
Payout Ratio(TTM) -- 23.68 43.75

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 358.89 7.43
Sales (TTM) vs TTM 1 Yr. Ago -- 90.38 5.80
Sales - 5 Yr. Growth Rate -- 31.32 10.19
EPS (MRQ) vs Qtr. 1 Yr. Ago -208.10 36.71 21.03
EPS (TTM) vs TTM 1 Yr. Ago -138.27 -- --
EPS - 5 Yr. Growth Rate -- 39.68 10.79
Capital Spending - 5 Yr. Growth Rate 22.82 39.59 15.12

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.98 2.28
Current Ratio (MRQ) 5.52 5.42 3.11
LT Debt to Equity (MRQ) 0.09 33.58 11.47
Total Debt to Equity (MRQ) 1.24 35.41 15.63
Interest Coverage (TTM) -120.23 -152.89 31.38

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 41.87 54.21
Gross Margin - 5 Yr. Avg. -- 49.14 51.98
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -506.71 11.83
Operating Margin (TTM) -- -728.63 4.90
Operating Margin - 5 Yr. Avg. -- -526.19 7.44
Pre-Tax Margin (TTM) -- -694.90 5.91
Pre-Tax Margin - 5 Yr. Avg. -- -531.06 7.89
Net Profit Margin (TTM) -- -696.67 2.16
Net Profit Margin - 5 Yr. Avg. -- -534.50 4.12
Effective Tax Rate (TTM) -- 25.12 23.36
Effective Tax Rate - 5 Yr. Avg. -- 20.63 24.15

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 25,687,363 898,926,015
Net Income/Employee (TTM) -2,959,909 2,194,067 106,550,787
Receivable Turnover (TTM) -- 18.46 5.94
Inventory Turnover (TTM) -- 2.61 3.62
Asset Turnover (TTM) 0.00 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -56.29 -1.11 11.50
Return on Assets - 5 Yr. Avg. -30.70 2.88 12.67
Return on Investment (TTM) -61.42 0.28 15.02
Return on Investment - 5 Yr. Avg. -32.77 1.84 16.45
Return on Equity (TTM) -61.71 0.94 16.60
Return on Equity - 5 Yr. Avg. -35.99 2.30 17.56
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -47.10 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Esperion Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 11.55 7.70 99 57
13 Week 20.24 14.38 99 62
26 Week 56.92 44.99 99 81
52 Week 315.45 252.13 99 47
YTD 348.96 294.28 99 60
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 206
Total Shares Held: 31,387,279
3 Mo. Net Change: -1,495,318
# New Positions: 30
# Closed Positions: 31
# Increased Positions: 89
# Reduced Positions: 92
# Net Buyers: -3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.